Aytu Biopharma, Inc SEC filings AYTU
Aytu Biopharma, Inc has 907 filings in SEC EDGAR's recent list, going back to Jan 11, 2007. Its latest annual report, Form 10-K, was filed on Sep 22, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 13, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 22, 2026 (results of operations). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 5, 2025 | — |
| CORRESP | Letter to the SEC | Jun 2, 2025 | — |
| CORRESP | Letter to the SEC | Jun 2, 2025 | — |
| UPLOAD | Letter from the SEC | May 1, 2025 | — |
| DRS | Filing | Apr 28, 2025 | — |
| EFFECT | Filing | Oct 15, 2024 | — |
| CORRESP | Letter to the SEC | Oct 7, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 3, 2024 | — |
| NT 10-K | Filing | Sep 29, 2023 | Jun 30, 2023 |
| EFFECT | Filing | Jun 8, 2023 | — |
| CORRESP | Letter to the SEC | Jun 7, 2023 | — |
| CORRESP | Letter to the SEC | Jun 7, 2023 | — |
| CT ORDER | Filing | May 16, 2023 | — |
| NT 10-Q | Filing | Feb 15, 2023 | Dec 31, 2022 |
| EFFECT | Filing | Jun 22, 2022 | — |
| CORRESP | Letter to the SEC | Jun 16, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 13, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 23, 2022 | — |
| CORRESP | Letter to the SEC | Feb 22, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 17, 2022 | — |
| CORRESP | Letter to the SEC | Feb 14, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2022 | — |
| CORRESP | Letter to the SEC | Feb 2, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 26, 2022 | — |
| EFFECT | Filing | Oct 7, 2021 | — |
| CORRESP | Letter to the SEC | Oct 6, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 5, 2021 | — |
| DEL AM | Filing | Sep 29, 2021 | — |
| 425 | Current report | Mar 22, 2021 | — |
| 425 | Form 425 | Feb 10, 2021 | — |
| EFFECT | Filing | Feb 9, 2021 | — |
| CORRESP | Letter to the SEC | Feb 8, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2021 | — |
| 425 | Form 425 | Jan 6, 2021 | — |
| 425 | Current report | Dec 15, 2020 | — |
| 425 | Current report | Dec 14, 2020 | — |
| 425 | Current report | Dec 10, 2020 | — |
| 425 | Current report | Dec 10, 2020 | — |
| 425 | Current report | Dec 10, 2020 | — |
| 425 | Current report | Dec 10, 2020 | — |
| NT 10-K | Filing | Sep 28, 2020 | Jun 30, 2020 |
| EFFECT | Filing | Jun 17, 2020 | — |
| EFFECT | Filing | Jun 17, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2020 | — |
| CORRESP | Letter to the SEC | Jun 12, 2020 | — |
| CORRESP | Letter to the SEC | Jun 12, 2020 | — |
| EFFECT | Filing | Feb 28, 2020 | — |
| CORRESP | Letter to the SEC | Feb 27, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 27, 2020 | — |
| 425 | Current report | Feb 14, 2020 | — |
| EFFECT | Filing | Jan 15, 2020 | — |
| 425 | Current report | Jan 15, 2020 | — |
| CORRESP | Letter to the SEC | Jan 14, 2020 | — |
| EFFECT | Filing | Jan 10, 2020 | — |
| 425 | Amendment no. 1 to form 8-k | Jan 10, 2020 | — |
| CORRESP | Letter to the SEC | Jan 7, 2020 | — |
| CORRESP | Letter to the SEC | Dec 31, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 30, 2019 | — |
| 425 | Filing | Dec 11, 2019 | — |
| 425 | Filing | Dec 3, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 2, 2019 | — |
| PRER14A | Filing | Nov 21, 2019 | — |
| CORRESP | Letter to the SEC | Nov 21, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2019 | — |
| D | Filing | Oct 31, 2019 | — |
| 425 | Filing | Oct 15, 2019 | — |
| 425 | Filing | Oct 15, 2019 | — |
| 425 | Filing | Oct 3, 2019 | — |
| 425 | Filing | Sep 26, 2019 | — |
| 425 | Filing | Sep 23, 2019 | — |
| 425 | Filing | Sep 12, 2019 | — |
| 425 | Filing | Sep 12, 2019 | — |
| EFFECT | Filing | Oct 4, 2018 | — |
| CORRESP | Letter to the SEC | Oct 3, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2018 | — |
| UPLOAD | Letter from the SEC | May 8, 2018 | — |
| CORRESP | Letter to the SEC | May 7, 2018 | — |
| UPLOAD | Letter from the SEC | May 7, 2018 | — |
| EFFECT | Filing | Mar 1, 2018 | — |
| CORRESP | Letter to the SEC | Feb 28, 2018 | — |
| CORRESP | Letter to the SEC | Feb 28, 2018 | — |
| EFFECT | Filing | Dec 1, 2017 | — |
| CORRESP | Letter to the SEC | Nov 30, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 30, 2017 | — |
| EFFECT | Filing | Oct 24, 2017 | — |
| CORRESP | Letter to the SEC | Oct 23, 2017 | — |
| CT ORDER | Filing | Oct 20, 2017 | — |
| CERTNAS | Auto-generated paper document | Oct 19, 2017 | — |
| 8-A12B | Filing | Oct 17, 2017 | — |
| CORRESP | Letter to the SEC | Sep 22, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2017 | — |
| D | Filing | Aug 24, 2017 | — |
| D | Filing | May 16, 2017 | — |
| EFFECT | Filing | Apr 25, 2017 | — |
| EFFECT | Filing | Apr 4, 2017 | — |
| SC TO-I/A | Filing | Mar 1, 2017 | — |
| EFFECT | Filing | Feb 8, 2017 | — |
| SC TO-I/A | Filing | Jan 31, 2017 | — |
| SC TO-I | Filing | Jan 27, 2017 | — |
| EFFECT | Filing | Oct 27, 2016 | — |
| CORRESP | Letter to the SEC | Oct 26, 2016 | — |
| CORRESP | Letter to the SEC | Oct 26, 2016 | — |
| CORRESP | Letter to the SEC | Oct 21, 2016 | — |
| CORRESP | Letter to the SEC | Oct 21, 2016 | — |
| CORRESP | Letter to the SEC | Oct 11, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2016 | — |
| EFFECT | Filing | Sep 19, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2016 | — |
| CORRESP | Letter to the SEC | Sep 16, 2016 | — |
| EFFECT | Filing | Jun 30, 2016 | — |
| CORRESP | Letter to the SEC | Jun 28, 2016 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2016 | — |
| EFFECT | Filing | May 2, 2016 | — |
| CORRESP | Letter to the SEC | Apr 29, 2016 | — |
| CORRESP | Letter to the SEC | Apr 29, 2016 | — |
| UPLOAD | Letter from the SEC | Apr 1, 2016 | — |
| CORRESP | Letter to the SEC | Apr 1, 2016 | — |
| PRER14A | Filing | Mar 30, 2016 | — |
| CORRESP | Letter to the SEC | Mar 30, 2016 | — |
| UPLOAD | Letter from the SEC | Mar 28, 2016 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2016 | — |
| EFFECT | Filing | Mar 11, 2016 | — |
| CORRESP | Letter to the SEC | Mar 9, 2016 | — |
| UPLOAD | Letter from the SEC | Mar 9, 2016 | — |
| EFFECT | Filing | Oct 23, 2015 | — |
| CORRESP | Letter to the SEC | Oct 22, 2015 | — |
| UPLOAD | Letter from the SEC | Oct 22, 2015 | — |
| EFFECT | Filing | Oct 15, 2015 | — |
| D/A | Filing | Sep 22, 2015 | — |
| EFFECT | Filing | Aug 10, 2015 | — |
| CORRESP | Letter to the SEC | Aug 7, 2015 | — |
| D | Filing | Aug 5, 2015 | — |
| CORRESP | Letter to the SEC | Jul 30, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 28, 2015 | — |
| CT ORDER | Filing | Jun 26, 2015 | — |
| NT 10-Q | Filing | May 15, 2015 | Mar 31, 2015 |
| D | Filing | Feb 4, 2011 | — |
| D | Filing | Jul 22, 2010 | — |
| D | Filing | Apr 10, 2009 | — |
| 10QSB | 10-qsb | Jul 15, 2008 | May 31, 2008 |
| 10QSB | Quarterly report - 2nd qtr ended 2/29/2008 | Apr 11, 2008 | Feb 29, 2008 |
| 10QSB/A | Amemdment #1 to form 10-qsb ended 11-30-2007 | Mar 11, 2008 | Nov 30, 2007 |
| 8-A12G | Form 8-a12g | Mar 4, 2008 | — |
| 10QSB | Report 10-qsb | Jan 11, 2008 | Nov 30, 2007 |
| 10QSB/A | Amendment 1 to form 10-qsb | Dec 26, 2007 | May 31, 2007 |
| REGDEX | Auto-generated paper document | Dec 6, 2007 | — |
| 10KSB | 10-ksb | Nov 21, 2007 | Aug 31, 2007 |
| 10QSB | Form 10qsb 3rd quarter | Jul 13, 2007 | May 31, 2007 |
| EFFECT | Filing | May 10, 2007 | — |
| CORRESP | Letter to the SEC | May 8, 2007 | — |
| CORRESP | Letter to the SEC | May 3, 2007 | — |
| SB-2/A | Amendment #3 to form sb-2 | Apr 27, 2007 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2007 | — |
| UPLOAD | Letter from the SEC | Apr 9, 2007 | — |
| SB-2/A | Amendmnet #2 to form sb-2 | Mar 30, 2007 | — |
| SB-2/A | Amendmnet #1 to form sb-2 | Mar 7, 2007 | — |
| UPLOAD | Letter from the SEC | Feb 13, 2007 | — |
| SB-2 | Form sb-2 | Jan 11, 2007 | — |
Showing 159 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AYTU (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Denver, CO
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1385818
- Former names
- AYTU BIOSCIENCE, INC (until Mar 22, 2021); Rosewind CORP (until Jun 8, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.